Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 04-2011 | 01-2011 | 10-2010 | 07-2010 | 04-2010 | |
| Sales | 316 | 330 | 133 | 122 | 40 |
| Cost of Goods | 240 | 279 | 76 | 83 | 49 |
| Gross Profit | 76 | 51 | 56 | 40 | -9 |
| Operating Expenses | 124 | 110 | 91 | 26 | 112 |
| Operating Income | -49 | -59 | -34 | 14 | -121 |
| Interest Expense | 58 | 57 | 43 | 43 | 41 |
| Other Income | -49 | -14 | 78 | 29 | 163 |
| Pre-tax Income | -156 | -130 | N/A | N/A | N/A |
| Net Income Continuous | -156 | -130 | -78 | -29 | -163 |
| Net Income | $-156 | $-130 | $-78 | $-29 | $-163 |
| EPS Basic Total Ops | -0.27 | -0.27 | 0.00 | 0.00 | -0.27 |
| EPS Basic Continuous Ops | -0.27 | -0.27 | 0.00 | 0.00 | -0.27 |
| EPS Diluted Total Ops | -0.27 | -0.27 | 0.00 | 0.00 | -0.27 |
| EPS Diluted Continuous Ops | -0.27 | -0.27 | 0.00 | 0.00 | -0.27 |
| EBITDA(a) | $-16 | $54 | $-32 | $73 | $-96 |